By Rich Haridy December 06, 2022 The SARS-CoV-2 spike protein (in red) enters human cells via a receptor called ACE2 (in blue). A study discovered a pre-existing drug can reduce the volume of ACE2 receptors on our cells, hypothetically reducing opportunities for viral infection. Depositphotos An impressive new study published in Nature is pointing to a new...
